Managing Immune Checkpoint Inhibitor Pneumonitis in the ICU

Recent advancements in the management of non-small cell lung cancer, especially with immunotherapeutic agents like immune checkpoint inhibitors (ICIs), have improved patient outcomes significantly. However, despite their effectiveness, ICIs can cause immune-related adverse events, including checkpoi...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristina Montemayor, MD, MHS, Mohammad I. Ghanbar, MD, Abigail L. Koch, MD, MHS, Karthik Suresh, MD, Robert Scott Stephens, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:CHEST Critical Care
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2949788424000807
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items